Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Billable / specificPOA exempt
Z79.818 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Long term (current) use of estrogen receptor downregulators
- Long term (current) use of fulvestrant (Faslodex)
- Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
- Long term (current) use of goserelin acetate (Zoladex)
- Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
- Long term (current) use of megestrol acetate (Megace)
Includes (from Z79)
- long term (current) drug use for prophylactic purposes
- Note: Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- Note: (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- Note: (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Excludes1
Not coded here — never report together with this code.
Excludes2
Not included here — may be reported together when both conditions exist.
Code first
Sequence the underlying condition first.
Use additional code
Add a code to identify the following, if applicable.
- code, if applicable, to identify: (from Z79.81)
- estrogen receptor positive status (Z17.0) (from Z79.81)
- family history of breast cancer (Z80.3) (from Z79.81)
- genetic susceptibility to malignant neoplasm (cancer) (Z15.0-) (from Z79.81)
- personal history of breast cancer (Z85.3) (from Z79.81)
- personal history of prostate cancer (Z85.46) (from Z79.81)
- postmenopausal status (Z78.0) (from Z79.81)
Code also
An additional code may be needed.
Also known as
- Long term (current) use of estrogen receptor downregulators
- Long term (current) use of fulvestrant (Faslodex)
- Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
- Long term (current) use of goserelin acetate (Zoladex)
- Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
- Long term (current) use of megestrol acetate (Megace)
- Long-term, agents affecting estrogen receptors and estrogen levels NEC
- Long-term, estrogen receptor downregulators
- Long-term, fulvestrant
- Long-term, gonadotropin-releasing hormoneagonist
- Long-term, goserelin acetate
- Long-term, leuprolide acetate
- Long-term, megestrol acetate
- Therapy, drug, long-term, agents affecting estrogen receptors and estrogen levels NEC
- Therapy, drug, long-term, estrogen receptor downregulators
- Therapy, drug, long-term, fulvestrant
- Therapy, drug, long-term, gonadotropin-releasing hormoneagonist
- Therapy, drug, long-term, goserelin acetate
- Therapy, drug, long-term, leuprolide acetate
- Therapy, drug, long-term, megestrol acetate
Parent code
- Z79.81Long term (current) use of agents affecting estrogen receptors and estrogen levelsHeader